Cytel excels at using proven quantitative techniques to transform real-world data into actionable insights
Bayer reported the highest market capitalization growth of 23.1% during Q1 2023
At commercial scale, Bluestem's patent pending technologies will reduce carbon emission by an estimated 75% or more and be cost-competitive with petroleum based chemicals
India is working towards augmenting health infrastructure and have initiated multiple schemes to strengthen health systems and improve health service delivery
The move will add new global talent to Cytel’s Strategic Consulting group
Construction is now underway with the facility scheduled to be operational by 2025
NATCO to sell 15% of shareholding in Nativita for euro 3,45,000 to Pharmasyntez-Nord
The acquisition reaffirms Infosys’ commitment to help global life sciences companies
The refocused commercial set-up will increase organizational efficiency and alignment across all commercial functions globally
Subscribe To Our Newsletter & Stay Updated
